El Hospital Universitario Son Espases es uno de los dos hospitales públicos con los que cuenta la ciudad de Palma de Mallorca, en España.

During the past decade, Hospital Son Espases conducted 248 clinical trials. In the 10-year time frame, 248 clinical trials started and 77 clinical trials were completed, i.e. on average, 31% percent of trials that started reached the finish line to date. In the past 5 years, 117 clinical trials started and 56 clinical trials were completed. i.e. 47.9% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Hospital Son Espases" #1 sponsor was "Hoffmann-La Roche" with 18 trials, followed by "Pfizer" with 14 trials sponsored, "Boehringer Ingelheim" with 10 trials sponsored, "Janssen Research & Development, LLC" with 10 trials sponsored and "Fundación GECP" with 10 trials sponsored. Other sponsors include 248 different institutions and companies that sponsored additional 144 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Hospital Son Espases" #1 collaborator was "Astellas Pharma Inc" with 5 trials as a collaborator, "Bristol-Myers Squibb" with 4 trials as a collaborator, "Hospital Clinic of Barcelona" with 4 trials as a collaborator, "Hospital Son Espases" with 4 trials as a collaborator and "Medivation LLC, a wholly owned subsidiary of Pfizer Inc." with 4 trials as a collaborator. Other collaborators include 170 different institutions and companies that were collaborators in the rest 141 trials.

According to Clinical.Site data, the most researched conditions in "Hospital Son Espases" are "Breast Cancer" (12 trials), "Multiple Myeloma" (9 trials), "Hemophilia A" (8 trials), "Crohn's Disease" (6 trials) and "Leukemia, Myeloid, Acute" (6 trials). Many other conditions were trialed in "Hospital Son Espases" in a lesser frequency.

Most popular intervention types in "Hospital Son Espases" are "Drug" (217 trials), "Other" (34 trials), "Device" (22 trials), "Biological" (18 trials) and "Procedure" (16 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (42 trials), "Carboplatin" (13 trials), "Paclitaxel" (12 trials), "Atezolizumab" (9 trials) and "Dexamethasone" (9 trials). Other intervention names were less common.

The vast majority of trials in "Hospital Son Espases" are 273 trials for "All" genders, 20 trials for "Female" genders and 20 trials for "Male" genders.

Currently, there are 123 active trials in "Hospital Son Espases". 4 are not yet recruiting, 77 are recruiting, 40 are Active, not recruiting, and 2 are Enrolling by invitation. In total, there were 146 completed trials in Hospital Son Espases, undefined suspended trials, and 24 terminated clinical trials to date.

Out of the total trials that were conducted in Hospital Son Espases, 9 "Phase 1" clinical trials were conducted, 81 "Phase 2" clinical trials and 113 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 20 trials, and there were also 15 trials that are defined as “Not Applicable".

Hospital Son Espases has several departments that took part in Clinical trials: "Hospital Universitario Son Espases; Servicio de Oncologia" - 12 trials